Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
-$0.17 today
- Market cap
- $271.79M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
Volume 0.05M
Average 0.04M
TTRX Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Turn Therapeutics Inc.NASDAQ: TTRX
Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) of $67.57K in Q1 FY2026
Q1 FY2026 property, plant & equipment (net) was $67.57K.
Context
- Property, plant & equipment (net) amounted to 0.4% of total assets at the end of Q1 FY2026.
- Property, plant & equipment (net) increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 120.45K | +262.6% |
| FY2023 | 2023-12-31 | 33.22K | — |
Property, Plant & Equipment (Net) vs competitors
How TTRX compares with its peers on the latest reported figures
- TTRX's Mar 2026 property, plant & equipment (net) of $67.57K is the 7th highest of the 9 companies compared; the peer median is $256K.
- Property, plant & equipment (net) amounts to 0.4% of total assets for TTRX, versus a peer median of 1.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $33.38M | -15.0% | -8.8% | 12.3% | |
| Mar 2026 | $22.41M | -84.4% | -47.2% | 12.0% | |
| Mar 2026 | $675.65K | +115.7% | +17.9% | 2.3% | |
| Mar 2026 | $326K | -48.6% | -27.5% | 0.9% | |
IRDOpus Genetics, Inc. | Mar 2026 | $186K | -22.2% | +221.3% | 0.3% |
| Apr 2026 | $173K | -18.0% | -3.1% | 1.2% | |
TTRXTurn Therapeutics Inc. | Mar 2026 | $67.57K | — | — | 0.4% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding TTRX) | $256K | -22.2% | -5.9% | 1.0% | |
Competitors are the stored peer set for TTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Turn Therapeutics Inc.
NASDAQ:TTRX
Intrinsic Alpha fair value
Locked
Current Price
$8.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.